title: Botulinum toxin in "refractory" detrusor overactivity. Re: Makovey I, et al. botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability. Neurourol Urodyn 2011;30:1538-1540.
authors.forename: Colin A
authors.initials: CA
authors.lastname: Walsh
authors.forename: Kate H
authors.initials: KH
authors.lastname: Moore
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D018579:Patient Selection; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
chemical_list: D000924:Anticholesteremic Agents; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A